by Danielle Bonadies | Jan 24, 2020 | News
A few months ago, I received an email from a company called Chronomics that tests for epigenetic changes in your DNA. I’m still a bit scarred from my personal direct-to-consumer testing experience, so I was initially reluctant to explore yet another genetic...
by Danielle Bonadies | Jan 2, 2020 | News
2019 was another banner year for precision oncology with the approval of a number of drugs targeting novel genomic alterations, the availability of a third pan-cancer indication, and the commercial launch of new biomarker tests for predicting drug response, such as...
by Danielle Bonadies | Jan 2, 2020 | News
In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether...
by Danielle Bonadies | Dec 27, 2019 | News
For years, many of us in the genetics community have strongly suggested that consumers think long and hard before ordering recreational genetic test kits for Christmas – or any other occasion. But when the Pentagon sends a stern warning to its military members, even...
by Danielle Bonadies | Dec 2, 2019 | News
People around the US, regardless of whether they live in a large city or a remote village, can now order genetic tests online to learn their inherited risks for serious diseases, such as cancer. But what do individuals do after they learn their risks? How do they find...
